Pharmacy Examining Board of Canada Part II – Format of Examination Stations and Sample Stations The Pharmacist Qualifying Examination – Part II (OSCE)

Sample Station #1 – Cancer Pain Control


Format of Examination Stations – Part II (OSCE)

The Qualifying Examination – Part II consists of both interactive and non-interactive stations.
Each station will require that you complete one or more short tasks such as:

 counselling or responding to questions from a “Standardized Patient” or Standardized Client
 interacting with a “Standardized Patient” or “Standardized Client” or “Standardized Health Professional” to   resolve a drug therapy problem or ethical dilemma
 responding in writing to a message or request for information/advice
 screening / evaluating new prescriptions
 checking dispensed prescriptions for accuracy prior to their release

You may be required to select and justify the best therapeutic option available. For example, in a situation involving a patient’s request for assistance in selecting an appropriate nonprescription remedy for symptomatic relief, limited products will be displayed and there will be one or more appropriate and inappropriate options. Even if you believe there is a better option than those provided, you must choose the most appropriate option(s) from those available.

In any situation, you are expected to use your professional and/or ethical judgement, and act in the best interests of the patient, in order to provide good patient care.  In most instances, you are required to assist the client in some way while the client is present in the station, not simply refer the client to another health professional nor indicate that you will call them back later with your response (although you may either refer or offer to call back in addition to providing appropriate assistance).

Five station examples, which are representative of the formats for three interactive stations and two non-interactive stations, are found below.

Reminder:

Part II (OSCE) examination is “open book”, but candidates may onlyuse the references which are provided in the stations.

Candidates should become familiar with these (listed) references in order to use them efficiently, if provided.

Some of the written prescriptions or patient records provided in some stations may have only the drug’s trade name or generic name. (Note that trade and generic drug names are cross-referenced in the green page section near the front of the CPS.)

Sample Station #1

Interactive Station (with a Standardized Patient) – involving a prescription medication

https://www.pebc.ca/prism_resource/classes/flv_player/player.swf

TITLE
Cancer Pain Control

OBJECTIVES:  

  • To educate an elderly patient on a new prescription for pain control
  • To identify and address the patient’s concerns regarding pain medications

COMPETENCIES TESTED

Competency 1 Patient Care

Elements
1.1
Develop a trusting professional relationship with the patient.
1.2 Gather patient information.
1.3 Assess the health status and concerns of the patient.
1.4 Identify the patient’s desired therapeutic outcomes.
1.5 Identify and prioritize actual and potential drug therapy problems.
1.6 Develop a therapeutic plan.
1.7 Support the implementation of a therapeutic plan.

 Competency 5 Communication and Education 

Elements
5.1
Demonstrate effective communication skills.

CANDIDATE’S INSTRUCTIONS:

A cancer patient who has been taking morphine sustained release tablets is experiencing increasing pain. He is now being started on morphine oral solution and has some questions and concerns about using it. Please assist him when he asks you for advice.

Time Frame:  You have 7 minutes to complete this station.

SCENARIO DESCRIPTION:

An elderly patient who has been taking long-acting morphine tablets for cancer pain was recently prescribed morphine liquid for breakthrough pain. The patient is hesitant to take the morphine liquid because when he first started taking morphine tablets he was constipated and quite groggy at times. He is afraid of taking too much morphine and is seeking the pharmacist’s advice.

Client:  Ted Wheaton, 70 year old male

Patient Background, Behaviour, Affect and/or Mannerisms:

  • Obvious discomfort (moving slowly and carefully).
  • Appears somewhat anxious.
  • Willing to listen to all advice from pharmacist.

Patient Record (Profile) Information:
Patient Name: Ted Wheaton
Gender: Male
Age: 70 years old
Allergies: None known
Medical History: Prostate cancer, diagnosed 3 years ago
Medications: Sustained release morphine sulfate tablets (MS Contin) 30 mg q 12 h (prescribed 2 months ago)
Morphine oral solution 1 mg/mL, 5 mL  every 4 – 6 hours when needed for pain; prescribed and filled yesterday

Patient’s Opening Statement:

“Hello, I just got this new prescription for morphine liquid yesterday. I am uncertain about how to use it along with my morphine pills, and what it will do to me if I take both of them. Would you explain to me how I should take it and anything else that I should know about it?”

Other Information  (Standardized Patient responds as follows, when asked):
Current symptoms, chronology:

  • Over the past two weeks he has experienced pain between doses of MS Contin.
  • He has more pain in the early evening (pain starts before the evening dose around 5:30-6 pm) and at night.
  • The pain is in his hips; it often limits his ability to take his evening walks.
  • He has trouble sleeping because of the pain.
  • He takes morphine pills at 8 a.m and 8 p.m.

Social / Lifestyle:

  • Non-smoker
  • Moderate alcohol intake – a beer or glass of wine once or twice a week
  • Lives alone in an assisted-living complex, with family support

Other:

  • He has never used morphine oral solution (or any liquid medication).
  • He did not start taking the liquid yesterday because he was concerned about how to take it along with the pills.
  • He has a dosing cup at home for the liquid.
  • He takes MS Contin 30 mg each morning and evening, and Tylenol Extra Strength in between if needed.
  • He tried Tylenol Extra Strength (1 tablet twice daily) a couple of times, but it did not help.
  • He cannot remember if the doctor said anything about taking or not taking the Tylenol.
  • He has occasional constipation, but not as much as when he first started taking morphine tablets.
  • He did not know what to take for the constipation (and does not know what to take for it); he is more concerned about taking care of the pain.
  • Does not take any other medications.

STANDARDIZED PATIENT INSTRUCTIONS:

Patient’s Opening Statement:

“Hello, I just got this new prescription for morphine liquid yesterday and I’m uncertain about how to use it along with my morphine pills, and what it will do to me if I take both of them. Would you explain to me how I should take it and anything else that I should know about it?”

If not told by the candidate, the Standardized Patient must ask:

 “Should I stop using my morphine pills and just use the liquid regularly?”
(if candidate does not explain the use of  both medications)

 “I’m just wondering how much I could take before I go to bed?”
(if candidate does not explain morphine liquid dosing)

“Will it make me groggy (like the morphine pills did)?”  OR “Will I have it with this too?”(grogginess)
(if candidate does not address drowsiness as a side effect)

By the 5-minute mark, if the candidate has not explained how to take both medications together or the safety or benefit of taking both tablets and liquid, the SP must say:

“I’m uncertain about what it will do to me if I take both of them together.”

ASSESSOR INFORMATION (to guide scoring of candidate’s performance):

Problem Solved (full solution) if candidate:

  • Explains use of both medications: to continue taking morphine tablets regularly AND to take liquid morphine if needed / when pain recurs.
  • Explains dosing of the morphine liquid.
  • Explains drowsiness side effect: the patient may initially experience more drowsiness (while taking both tablets and liquid) and that it will lessen.

Solved/Marginal (partial solution) if candidate:

  • Explains use of both medications, but less thoroughly.
  • Explains dosing of morphine liquid, but less thoroughly (e.g. misses bedtime dose).
  • Explains drowsiness side effect, but less thoroughly (e.g. does NOT indicate that it will lessen).

Uncertain if candidate:

  • Explains use of both medications.
  • Explains dosing of the morphine liquid OR side effects, NOT BOTH.
    Unsolved if candidate:
  • Provides incorrect dosing information (resulting in potential treatment failure or potential harm).
  • Suggests taking either liquid or tablets, NOT both.
  • Suggests stopping / not taking liquid morphine OR taking both may be unsafe.
  • Suggests taking Tylenol first, then morphine liquid if Tylenol ineffective (delays effective therapy, prolongs pain)

STATION MATERIALS AND REFERENCES:

Patient Record (Profile):      information as on previous page
Reference:                             CPS

PATIENT RECORD                                                                      

PATIENT: WHEATON, Ted AGE: 70 years old
ADDRESS: 69 Hampton Crescent
City, Province
GENDER: Male
PHONE: 223-6778 ALLERGIES: None known
PHYSICIAN: Dr. T. Warden COMMENTS: Prostate cancer x 3 years
ADDRESS: 100 – 3433 Wood Avenue
City, Province
PHONE: 246-8943

 

Rx # Medications- Directions Qty Physician Repeats Authorized Repeats Remaining

Dispensing Intervals

Original Refill
Frequency
Last Filled

2

Morphine Oral Sol’n 1mg/mL
Take 5 mL every 4 to 6 hours if needed for pain.
250 mL T. Warden 0 0 yesterday

1

Morphine (MS Contin) 30 mg

Take one tablet every 12 hours.

100 T. Warden 0 0 2 months ago 2 months ago

EXAMINATION MASTER

Please do not mark in any way.

CHECKLIST (expected candidate responses)

1. Confirms that patient takes long-acting morphine every twelve hours.

2. Determines that patient is experiencing recurrence of pain between doses of long-acting morphine.

3. Explains that MS Contin is a long-acting pain killer and morphine liquid is short-acting/used for breakthrough pain.

4. Explains use of both medications:

□ both medications should be taken / it is safe to take both medications
□ do not stop taking morphine tablets / take morphine tablets regularly (as before)
□ take liquid morphine if needed / if pain recurs / for “breakthrough” pain

5. Explains dosing of morphine liquid:

□ 5 mL every 4 to 6 hours if needed for pain
□ 5 mL before bedtime (to help control pain overnight)

6. Suggests keeping a log (recording) of each dose of liquid morphine (to review with doctor / to reassess pain control.) Suggests contacting doctor if liquid morphine is needed often/if pain not controlled.

7. Asks about side effects (e.g., drowsiness, constipation).

Explains drowsiness side effect:

□ the added (liquid) morphine may cause more drowsiness
□ drowsiness will lessen (as the body gets used to the added morphine)

8. Recommends measures to alleviate constipation:  laxative or non-drug measures, e.g., increased fibre and fluid intake.

9. Determines that the patient tried Tylenol / that Tylenol was ineffective.

10. Suggests stopping Tylenol.

11. Incorrectly explains (Unsolved):

□ incorrect dosing, e.g., to take morphine liquid regularly
□ to take either morphine tablets OR liquid, NOT both
□ to stop/NOT take liquid morphine OR taking both may be unsafe
□ to try Tylenol first, then take liquid morphine if Tylenol ineffective (delays effective therapy, prolongs pain)

RATINGS (to be based on standard scoring guidelines and Assessor Information above):

Communications
4=Acceptable
3=Acceptable/Marginal
2=Unacceptable/Marginal
1=Unacceptable
Outcome
4=Problem Solved
3=Solved/Marginal
2=Uncertain
1=Unsolved
Performance
4=Acceptable
3=Acceptable/Marginal
2=Unacceptable/Marginal
1=Unacceptable

Misinformation
Yes   No
Risk to Patient
Yes   No

Sample Station #2

Interactive Station (with a Standardized Patient) – involving a nonprescription medication

https://www.pebc.ca/prism_resource/classes/flv_player/player.swf

TITLE
Travellers’ Diarrhea

OBJECTIVE
To interview a patient seeking assistance in selecting an appropriate nonprescription medication, to gather appropriate information, to assess the patient’s needs and to recommend appropriate drug therapy and preventive non-drug measures.

COMPETENCIES TESTED

Competency 1 Practise Pharmaceutical Care

Elements
1.1
Develop a trusting professional relationship with the patient.
1.2 Gather patient information.
1.4 Identify the patient’s desired therapeutic outcomes.
1.5 Identify and prioritize actual and potential drug therapy problems.
1.6 Develop a therapeutic plan.
1.7 Support the implementation of the therapeutic plan.
1.8 Monitor the patient’s progress and assess therapeutic outcomes.

Competency 5 Communication and Education

Element
5.1
Demonstrate effective communication skills.

CANDIDATE’S INSTRUCTIONS:

A patient is coming in to ask your advice regarding “travellers’ diarrhea”. She is leaving tomorrow for a tropical vacation. Respond as you would in practice.

Time Frame: You have 7 minutes to complete this station.

SCENARIO DESCRIPTION

Client: Standardized Patient – Amy Kletchko, female, ambulatory, 22 years old.

Ms. Kletchko is busy with last minute preparations for a vacation at a coastal resort in Cancun, Mexico where she plans to enjoy the beach and take some tours to the pyramids, as well. The day before leaving she goes to her regular pharmacy to ask about some nonprescription medication to treat “travellers’ diarrhea”, having been advised by her travelling companion, who has been in Mexico before, that there is a high risk of getting it.

Patient Background, Client Behaviour, Affect and/or Mannerisms:

When she goes in to see the pharmacist (candidate), she is pleasant, excited, and has confidence in the pharmacist.

Patient Information (there is no patient record – patient gives this information to candidate on request):

Patient Name: Amy Kletchko
Gender: Female
Age: 22 years old
Allergies: Acetylsalicylic acid (ASA, Aspirin) – reaction is hives and shortness of breath
Current Medications: None
Social/Lifestyle:
 Non-smoker
 Moderate alcohol intake – 3 or 4 alcoholic drinks per week
History:
 Skin burns quite easily when out in the sun.
 Taking Aspirin (ASA) resulted in hives and shortness of breath.
 Has a MedicAlert bracelet (for her allergy) – she doesn’t always wear it.

STANDARDIZED PATIENT INSTRUCTIONS

Patient’s Opening Statement:

“Hi, I’m leaving tomorrow morning for a vacation in Mexico. I’d like to take something along in case I get travellers’ diarrhea. My friend gave me a bottle of Pepto Bismol tablets. Would that be a good choice for me?”

If the candidate does not respond to the Standardized Patient’s question about Pepto Bismol (and/or simply recommends something else), the SP must say:

“My friend gave me a bottle of Pepto Bismol to take with me. She just bought it here recently, before she went on a cruise, but she didn’t  use it. I was just wondering if it would be okay to use that instead of buying something else.”

ASSESSOR INFORMATION (to guide scoring of candidate’s performance)

Problem solved (full solution) if candidate:
 Asks about/confirms history of ASA allergy, including the nature of the reaction
 Recommends appropriate therapy:
▫ do NOT take Pepto Bismol – contains salicylate which may provoke allergic reaction
▫ take Imodium (loperamide) to control travellers’ diarrhea
 Recommends appropriate dosage
 Recommends supportive non-drug measures for diarrhea (fluid and/or electrolyte replacement)
 Emphasizes to seek medical treatment immediately for diarrhea accompanied by fever and/or blood in feces
 Recommends preventive measures: use only bottled water for drinking water and making ice; wash with bottled water and/or peel fresh fruit and vegetables; avoid salads – unless in a hotel which follows the same precautions

Solved/Marginal (partial solution) if candidate:
 Confirms/mentions ASA allergy, but does NOT ask about the nature of the reaction
 Recommends appropriate therapy, including:
▫ do NOT take Pepto Bismol – but does NOT explain why
▫ take Imodium (loperamide) to control travellers’ diarrhea
 Recommends appropriate dosage
 Does NOTrecommend supportive non-drug measures for diarrhea (fluid and/or electrolyte replacement)
 Recommends seeking medical treatment if diarrhea persists or other symptoms occur (non-specific)
 Recommends drinking only bottled water (or soft drinks, etc.), but does NOT advice regarding fresh foods

Uncertain if candidate:
 Does NOT mention allergies OR does NOT relate ASA allergy to Pepto Bismol
 Recommends Imodium (loperamide) for travellers’ diarrhea, without cautioning NOT to use Pepto Bismol
 Recommends seeking medical treatment/follow-up if diarrhea persists or other symptoms occur (non-specific)
 Does NOT discuss prevention

Unsolved if candidate:
 Agrees that Pepto Bismol would be appropriate OR
 Does NOTrecommend medical treatment/follow-up for persistent/infectious/complicated diarrhea

STATION MATERIALS AND REFERENCES

References:
CPS
Therapeutic Choices

Nonprescription Medications:
Imodium tablets or caplets
Metamucil
Pepto Bismol tablets
Pedialyte 1L and 2L
Gastrolyte

CHECKLIST (expected responses)

1. Confirms/mentions ASA allergy.

2. Determines nature of ASA allergy/reaction.

3. Recommends: Do NOT take Pepto Bismol.

4. Explains: Pepto Bismol contains salicylate (Aspirin-like substance) and may cause an allergic reaction.

5. Recommends appropriate therapy for travellers’ diarrhea.
 Imodium (loperamide).

6. Recommends appropriate dose:
 Imodium: two capsules to start, then one capsule after each loose bowel movement, to a maximum of 8 capsules daily.

7. Recommends immediate medical attention for diarrhea accompanied by any of:
 fever,
 blood in stool,
 persistent vomiting.

8. Discusses prevention of diarrhea:
 use only bottled water for drinking water, making ice, brushing teeth,
 wash fresh fruit and vegetables using bottled water OR peel them before eating,
 avoid salads unless in a hotel which follows these same precautions.

9. Discusses supportive measures for diarrhea:
 if diarrhea lasts several days use Gastrolyte or Pedialyte to maintain electrolyte balance,
 increase fluid intake and avoid dairy products.

10. Suggests wearing a MedicAlert bracelet/tag with ASA allergy information.

SCORES (to be based on standard scoring guidelines and the Assessor Information above):

Communications
4=Acceptable
3=Acceptable/Marginal
2=Unacceptable/Marginal
1=Unacceptable
Outcome
4=Problem Solved
3=Solved/Marginal
2=Uncertain
1=Unsolved
Performance
4=Acceptable
3=Acceptable/Marginal
2=Unacceptable/Marginal
1=Unacceptable

Misinformation
Yes   No
Risk to Patient
Yes   No

Sample Station #3 

Non-interactive Station – involving screening new prescriptions

TITLE
Screening New Prescriptions

OBJECTIVE
To effectively screen new prescriptions to identify and describe any errors, omissions or concerns.

COMPETENCIES TESTED

Competency 1 Patient Care

Element
1.5
Identify and prioritize actual and potential drug therapy problems.

Competency 3 Ethical, Legal and Professional Responsibilities

Element
3.1
Apply legal and ethical requirements including federal and provincial/territorial legislation, policies, by-laws and standards.

CANDIDATE’S INSTRUCTIONS:

1. Before you enter the station:
 Take one Candidate Answer Sheet from the folder marked “For Candidates Only”, on the door or wall outside the station. (Do NOT take anything from any other folder.)
 Attach one bar code label to the Candidate Answer Sheet in the space indicated.
2. When the start buzzer sounds:
 Enter the station and begin immediately.
 Find the CPS and written prescriptions on the desk/table.

3. Do the exercise:
 There are five (5) WRITTEN PRESCRIPTIONS to be assessed. They are taped to the desk/table.
 Some of the written prescriptions have ONE OR MORE problems to be resolved before they can be processed and filled by a pharmacy technician.

For each WRITTEN PRESCRIPTION:
1. Determine if it is ready to be processed and filled by a pharmacy technician.
2. If there is no problem to be resolved before processing or filling the prescription, fill in the bubble beside ”No problem – may be processed and filled as written”.
3.If there are any problem(s) that need to be resolved, fill in the bubble beside “Problem(s)” and clearly describe the PROBLEM(S) in the space provided.

4. When the final buzzer sounds:
 Stop writing immediately.
 Turn your completed Candidate Answer Sheet over (answer side down) on the desk/table, to be collected by examination staff.
 Proceed to the next station, taking your notebook (with bar codes) with you.

Time Frame: You have 7 minutes to complete this station.

Important:
 Do not mark the reference materials or written prescriptions in any way. Do not write over any bubbles on the Candidate Answer Sheet as it will render the sheet invalid.

WRITTEN PRESCRIPTIONS (not provided here in full but would show the following problems)

Rx 1 Paroxetine (Paxil) 20mg – mitte: 4 weeks
Answer: Problem.
Description: no dosing information.

Rx 2 Acyclovir (Zovirax) ointment – apply 4-6 times daily to affected area, for shingles; mitte 30 g
Answer: Problem.
Description: inappropriate route of administration.

Rx 3 Diltiazem (Cardizem) 30 mg qid x 1 month for angina
Answer: No problem – may be processed as written.

Rx 4 Amoxicillin (Amoxil) 250 mg, cap i tid x 7 days for Jamie, Celine and Dalia
Answer: Problem.
Description: prescription for more than one person on one order is unacceptable/illegal.
Rx 5 Cefuroxime (Ceftin) – i bid x 7 days
Answer: Problem.
Description: no strength specified.

CANDIDATE ANSWER SHEET FORMAT

Rx1 .Paxil 20mg – mitte: 4 weeks
.     No problem – may be processed as written
    Problem(s) – describe PROBLEM (S) clearly:
Incomplete dose information

SCORING INFORMATION:

Solved Fully if 5/5 correct

Solved Marginally if 3/5 or 4/5 correct

Uncertain if 2/5 correct        

Unsolved if 0/5 or 1/5 correct

STATION MATERIALS AND REFERENCES
CPS
Printed prescriptions (five)
Sample Station #4

Non-interactive Station – involving checking dispensed prescriptions

TITLE
Checking Dispensed Prescriptions
OBJECTIVE
To check dispensed medications and identify any corrections that must be made before the medications can be released.

COMPETENCIES TESTED

Competency 6 Drug Distribution

Elements 6.1 Apply relevant knowledge in the performance of tasks related to drug distribution.
6.2 Demonstrate the ability to supervise drug distribution.

Competency 7Understanding Management Principles   

Element 7.1 Supervise personnel such that delegated functions are carried out to meet accepted standards.

CANDIDATE’S INSTRUCTIONS:

1. Before you enter the station:
 Take one Candidate Answer Sheet from the folder marked “For Candidates Only”, on the door or wall outside the station. (Do NOT take anything from any other folder.)
 Attach one bar code label to the Candidate Answer Sheet in the space indicated.

2. When the buzzer sounds:
 Enter the station and begin immediately.
 Find the CPS, dispensed medications and corresponding written prescriptions on the desk / table.

3. Do the exercise:
 There are four (4) DISPENSED MEDICATIONS to be assessed. The corresponding written prescriptions are taped to the desk/table.
 Some of the medications have ONE OR MORE problems to be corrected before releasing them to the patients.

For each DISPENSED MEDICATION:
1. Determine if it is ready to be released to a patient.
2. If it is ready to be released, fill in the bubble beside “No correction(s) required – may be released as filled.”
3. If any correction(s) are required, fill in the bubble beside “Correction(s) required” and clearly specify the necessary CORRECTION(S) in the space provided on the answer sheet.
NOTE: If there is a problem, clearly specify the CORRECTION(S), not the problem.

4. When the final buzzer sounds:
 Stop writing immediately.
 Turn your completed Candidate Answer Sheet over (answer side down) on the desk/table, to be collected by examination staff.
 Proceed to the next station, taking your notebook (with bar codes) with you.

Time Frame: You have 7 minutes to complete this station.

Important:
 You are not to physically correct any problem.  Only record the necessary correction(s) in the space provided on the Candidate Answer Sheet.
 The prescriptions are correctly written and any therapeutic problems have been resolved.
 The omission of auxiliary labels is not to be considered a problem.
 Do not write over any bubbles on the exam paper as it will render the exam sheet invalid.
 Do not mark the product labels, reference materials, or written prescriptions in any way.

WRITTEN PRESCRIPTIONS (only one example is provided; there will be four prescriptions in total):

Written Rx1

DISPENSED MEDICATIONS (only one example is provided; there will be four dispensed medications in total):

Dispensed Rx1 Label

CANDIDATE ANSWER SHEET FORMAT:
Sample Answer Format

Rx1 .
.     No corrections required – may be released as filled
    Correction(s) required – specify CORRECTION(S)clearly:

Patient name on label should be “Veda Simmonds”

NOTE: An answer that states “Wrong patient name” would be incorrect as it does not specify the actual correction. (It only describes the problem.)

SCORING INFORMATION:

Solved Fully if 4/4 correct
Solved Marginally if 3/4 correct
Uncertain if 2/4 correct
Unsolved if 0/4 or 1/4 correct

STATION MATERIALS AND REFERENCES:

CPS
Written prescriptions (four)
Corresponding Dispensed Prescriptions (four)
Stock bottles

Sample Station #5

Interactive Station (with a Standardized Health Professional)

TITLE
Warfarin / Carbamazepine Interaction

OBJECTIVE
To identify and explain a drug/drug interaction problem and recommend an appropriate solution.

COMPETENCIES TESTED
Competency 1 Patient Care

Elements 1.5 Identify and prioritize actual and potential drug therapy problems.
1.6 Develop a therapeutic plan.
1.8 Monitor the patient’s progress and assess therapeutic outcomes.

Competency 4 Drug, Therapeutic and Practice Information

Element 4.3 Retrieve information from relevant sources

Competency 5 Communicate and Educate Effectively

Elements 5.1 Demonstrate effective communication skills.
5.1 Demonstrate comprehension and fluency in English or French.
5.2 Demonstrate sensitivity, respect and empathy when communicating with diverse groups or individuals.

CANDIDATE’S INSTRUCTIONS:

You are working in a pharmacy in a medical clinic. A physician is waiting in the pharmacy to give you a new written prescription for one of her patients.
 Attach one bar code label to the new prescription form – in the space indicated.
 You may use the blank space beside the prescription for making rough notes.
 The patient record is on the desk/table, for your reference.

Your tasks are to:
1. Review the prescription for any drug therapy problem(s).
2. You may speak with the physician if:
a. you need more information
b. you wish to discuss the patient’s therapy
3. You must speak directly to the physician to:
a. identify and explain any drug related problem(s)
b. recommend an appropriate solution to the problem(s)
4. If no change is necessary, fill in the bubble beside “Fill as written”
OR
5. If a change of therapy is recommended:
a. fill in the bubble beside “change or clarify..”
b. specify an appropriate drug and/or other option/s
c. document any change(s) on the prescription review form

When you have finished (or when the final buzzer sounds), give this prescription form to the assessor for scoring.

Note: You are NOT required to dispense the prescription or counsel the patient.

Time Frame: You have 7 minutes to complete this station.

SCENARIO DESCRIPTION

Earlier in the day Dr. Gaucher wrote a new prescription for one of her patients. (See candidate answer sheet for actual prescription). The physician is waiting in the pharmacy if the pharmacist (candidate) needs to speak to the physician about the new prescription. The candidate may ask the physician questions if the candidate identifies any drug related problems with the prescription. The physician will respond as appropriate.

Client: Standardized Physician – Dr. Jean Gaucher

Patient Record (Profile) Information (see below):
Patient Name: Chris Langley
Gender: Male
Age: 55 years old
Weight: 80 kg (180 lbs)
Medical History: Deep vein thrombosis (DVT) – diagnosed 5 weeks ago
Trigeminal neuralgia – newly diagnosed
Allergies: None known
Current Medications: Warfarin 5 mg daily – started 5 weeks ago in hospital.
Other information (Physician gives this information to candidate upon request):

Symptoms:
 Patient has pain in face (trigeminal neuralgia).

Other:
 Patient had a leg injury playing recreational floor hockey, followed by deep vein thrombosis in the left leg. He will be on warfarin for several more months…depending on resolution of symptoms (pain, edema).
 Patient was in hospital for one week following the DVT.
 Dr. Gaucher will be seeing him again in one month. His INR has been quite stable at 2.5 and was last checked just a few days ago. Dr. Gaucher is agreeable to ordering (at the candidate’s suggestion) more frequent lab work.

STANDARDIZED HEALTH PROFESSIONAL (PHYSICIAN) INSTRUCTIONS:

Opening Statement:

Hello, I’m Dr. Gaucher. I’ll be here if you need to speak with me about Chris Langley’s prescription.”

When the candidate consults with the Standardized Health Professional (SHP), the SHP replies as follows.

If the candidate recommends a change without identifying the problem, the SHP must ask:
“What is the problem?”

If the candidate identifies the problem but does not explain it, the SHP must ask:

“Do you know how the interaction works – can you give me a bit more information?”

Following discussion of the problem, if the candidate has not yet offered a recommendation, the SHPmust ask:

“What would you suggest to resolve the problem?”

If the candidate wants to change the Tegretol to a different drug, the SHP must say:

“I have had a lot of success with carbamazepine in trigeminal neuralgia…so I prefer to use it.  Do you have any other suggestions?”

If the candidate discourages use of carbamazepine and warfarin concurrently or still wants to change the Tegretol to an alternate drug, the SHP must say:

“I’ll take that under advisement and note your concern here, but for now I want him on both.”

If the candidate recommends more frequent monitoring as a general precaution, without identifying or explaining the interaction, the SHP must ask:

“What do you think the results would show?”

If the candidate identifies the problem and suggests monitoring INR as before, without discussing frequency, the SHP must say:

“He’s going for monthly blood work so will have another test in about 3 or 4 weeks.”

ASSESSOR INFORMATION (to guide scoring of candidate’s performance):

Problem Solved (full solution) if candidate:
 Identifies the drug therapy problem: carbamazepine – warfarin drug interaction.
 Explains the mechanism of the interaction: carbamazepine induces warfarin metabolism/cytochrome P450 enzymes.
 Explains probable outcome of the interaction: expect a decreased INR/decreased anticoagulant effect.
 Recommends to fill as written/use of both carbamazepine as ordered AND to monitor INR more frequently – OR to change to another acceptable drug, e.g. gabapentin.
 Explains that, when taking both medications, warfarin dose may need to be increased (to maintain a therapeutic INR).

Solved/Marginal (partial solution) if candidate:
 Identifies the drug therapy problem: carbamazepine – warfarin drug interaction.
 Explains either the mechanism of action OR probable outcome (NOT both).
 Recommends to fill as written/use of both carbamazepine as ordered AND to monitor INR more frequently – OR to change to another acceptable drug, e.g., gabapentin.
 Explains that warfarin dose may need to be adjusted, but does not specify that it may need to be increased.

Uncertain if candidate:
 Identifies the drug therapy problem: carbamazepine – warfarin drug interaction.
 Does not explain either the mechanism of the interaction or the probable outcome OR explanation is unclear.
 Recommends NOT using carbamazepine and warfarin together but does NOT suggest a solution.
 Recommends increased INR monitoring.

Unsolved if candidate:
 Does NOT identify the carbamazepine – warfarin drug interaction.
 Incorrectly explains the interaction (e.g. carbamazepine inhibits warfarin metabolism or results in increased INR or enhanced anticoagulation), leading to potential risk.
 Does NOT recommend increased INR monitoring.
 Recommends unacceptable solution (i.e. change to phenytoin, with or without monitoring; stop warfarin; decrease dose of warfarin).

STATION MATERIALS AND REFERENCES:

Patient record (profile): – see below
Reference: CPS

PATIENT RECORD – Sample Station #5

PATIENT: LANGLEY, Chris
ADDRESS: 731 3rd, City, Province
PHONE: 775-9990
AGE: 55 years old
SEX: Male
ALLERGIES: None known
COMMENTS: Deep vein thrombosis – diagnosed 5 weeks ago
PHYSICIAN: Dr. J. Gaucher
ADDRESS: 1655 West Broadway, City, Province
PHONE: 879-8874

Rx
#
Medications – Directions
Qty
Physician
Repeats
Authorized
Repeats Remaining
2
Warfarin (Coumadin) 5 mg
1 tablet daily
60
J. Gaucher
0
0
1
Amoxicillin (Amoxil) 250 mg
1 cap tid x 7 days
21
J. Gaucher
0
0
Dispensing Intervals
Original
Refill
Frequency
Last
Filled
4 weeks ago
q60 days
4 weeks ago
2 months ago
2 months ago

EXAMINATION MASTER
Please do not mark in any way.

CHECKLIST (expected responses)

1. Determines (from patient record) that patient is currently taking warfarin.
Identifies and explains:
2. Drug interaction between warfarin and carbamazepine.
3. Carbamazepine increases the metabolism of warfarin / induces cytochrome P450 enzymes.
4. Carbamazepine – warfarin interaction results in decreased INR / decreased anticoagulant effect.
5. Warfarin dose may need to be increased (to maintain a therapeutic INR).
6. Recommends acceptable solution (one of the following):
 Continue carbamazepine as ordered (fill as written) and monitor INR more frequently
OR
 Change carbamazepine to other acceptable drug therapy
▫ Neurontin (gabapentin)
▫ Depakene (valproic acid)
▫ Rivotril (clonazepam)
7. Gives incorrect explanation OR recommends unacceptable solution (Incorrect
response
):
 Carbamazepine decreases metabolism of warfarin OR increases INR
 Warfarin doses may have to be decreased
 Continue monitoring INR monthly (no increased frequency)
 Change to phenytoin (with or without monitoring)
 Discontinue warfarin
8. Correctly documents consultation / outcome on prescription / answer sheet.
9. Indicates “Fill as written” WITHOUT advising to monitor INR more frequently. (Incorrect response)

SCORES (to be based on standard scoring guidelines and Assessor Information above)

Communications
4=Acceptable
3=Acceptable/Marginal
2=Unacceptable/Marginal
1=Unacceptable
Outcome
4=Problem Solved
3=Solved/Marginal
2=Uncertain
1=Unsolved

Risk to Patient
Yes No

Performance
4=Acceptable
3=Acceptable/Marginal
2=Unacceptable/Marginal
1=Unacceptable

Misinformation
Yes No

Comments are closed.